Article
Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome.
Human genetics - 1 Jun 2011
Wu Chih-Chieh, Krahe Ralf, Lozano Guillermina, Zhang Baili, Wilson Charmaine D, Jo Eun-Ji, Amos Christopher I, Shete Sanjay, Strong Louise C
Abstract excerpt
Li-Fraumeni syndrome (LFS) is a rare familial cancer syndrome characterized by early cancer onset, diverse tumor types, and multiple primary tumors. Germ-line TP53 mutations have been identified in most LFS families. A high-frequency single-nucleotide polymorphism, SNP309 (rs2279744), in MDM2 was recently confirmed to be a modifier of cancer risk in several case-series studies: substantially earlier cancer onset...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
